Evidence map›Paper›PMID 35505254›Full record

ReviewNature reviews. Neuroscience2022

Macroautophagy in CNS health and disease.

Christopher J Griffey, Ai Yamamoto

Open access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
19.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 134 citations in OpenAlex.

  1. Article
  2. Autophagy in Melanoma: Molecular Mechanisms and Therapeutic Perspectives.International journal of molecular sciences · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Christopher J GriffeyDoctoral Program in Neurobiology and Behaviour, Medical Scientist Training Program, Columbia University, New York, NY, USA.ORCID 0000-0003-3781-8087
Ai YamamotoDepartments of Neurology, and Pathology and Cell Biology, Columbia University, New York, NY, USA. ai.yamamoto@columbia.edu.
Columbia University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007367 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI REINER, STEVEN L · 1985 to 2021
$25.1M
Modulating selective autophagy to modify Huntington's diseaseR01NS077111 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Ai Yamamoto · 2012 to 2026
$4.3M
Autophagy and NeurodegenerationR01NS063973 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MELIA, THOMAS JAMES, YAMAMOTO, AI · 2008 to 2019
$3.8M
Selective autophagy in Parkinson'sdiseaseR01NS101663 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Ai Yamamoto · 2018 to 2026
$3.1M
The role of autophagy in the neurovascular unit for the physiological response to stress.R21NS118891 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI AGALLIU, DRITAN, YAMAMOTO, AI · 2020 to 2020
$438k
The role of Parkin in mitophagy and dopaminergic neuron homeostasisF31NS118897 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GRIFFEY, CHRISTOPHER JOSEPH · 2021 to 2022
$93k
NIGMS NIH HHS T32 GM007367NINDS NIH HHS F31 NS118897NINDS NIH HHS R01 NS063973NINDS NIH HHS R01 NS077111NINDS NIH HHS R01 NS101663NINDS NIH HHS R21 NS118891
6 · The paper itself

Abstract

Macroautophagy is an evolutionarily conserved process that delivers diverse cellular contents to lysosomes for degradation. As our understanding of this pathway grows, so does our appreciation for its importance in disorders of the CNS. Once implicated primarily in neurodegenerative events owing to acute injury and ageing, macroautophagy is now also linked to disorders of neurodevelopment, indicating that it is essential for both the formation and maintenance of a healthy CNS. In parallel to understanding the significance of macroautophagy across contexts, we have gained a greater mechanistic insight into its physiological regulation and the breadth of cargoes it can degrade. Macroautophagy is a broadly used homeostatic process, giving rise to questions surrounding how defects in this single pathway could cause diseases with distinct clinical and pathological signatures. To address this complexity, we herein review macroautophagy in the mammalian CNS by examining three key features of the process and its relationship to disease: how it functions at a basal level in the discrete cell types of the brain and spinal cord; which cargoes are being degraded in physiological and pathological settings; and how the different stages of the macroautophagy pathway intersect with diseases of neurodevelopment and adult-onset neurodegeneration.

Indexed as

Central Nervous System DiseasesMacroautophagyAnimalsMammals

Identifiers

PMID35505254
PMCPMC9282724
OpenAlexW4225331347

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.